In the first Series A round funding, Mindstrong Health raised $14 million for their Neurological services. The organization is focusing on financing and supporting the diagnostic medicine and neuropsychiatric treatments. Interactive Smartphone devices have been developed to power Mondstrong’s new initiatives.
Foresite Capital led the first round of collections. The new test on digitalized diagnostic equipment aims at increasing intelligence of biomarkers. To this extent, it can give cognizance to mood, memory, speed and receptive abilities, and brain function. It collaborated with the following firms:
Optum Ventures who joined them later
Berggruen Holdings limited
The Brain Health Impact
Mindstrong Health understands the challenges faced by victims and patients with cognitive disorders and mental deficiencies. With this in mind, Rick, Paul, and Tom developed the innovative Smartphone gadgets with the potential to solve these psychiatric problems.
About Jim Tananbaum
Jim Tananbaum has been a leader in the entrepreneurial healthcare industry, with 25 years’ experience. He seeks financial opportunities, operational solutions, and strategy with modern technologies. He had co-founded the GelTex Pharmaceuticals upon graduating from Harvard University. According to pelotontherapeutics.com, he established himself as an entrepreneur in the medical field.
Tananbaum attended Yale University where he graduated with a Bachelor of Science degree and a Master’s of Science degree. He also attended Harvard University, graduating with a Master’s in Business Administration. Tananbaum was appointed to serve on the Advising Committee of the Harvard MIT Program and Yale’s Presidential Advisory Council due to his education and professional experience. He has previously served on the advisory boards for various medical institutions. Jim plays a significant role in other organizations such as:
o Founding partner of the Prospect Venture Partners II and III
o Founding partner at the Sierra Ventures
o He worked with the Amira Pharmaceuticals, Amerigroup, and Jazz Pharmaceuticals
o He crowned his experiences by founding the Foresite Capital Venture and making it his investment.
o inc42.com adds he’s been on the Forbes Midas top 100 investors of 2017